Monoclonal antibodies against IgE-associated determinants, hybrid cell lines producing these antibodies, and use therefore
US4940782A · kind A · utility
46Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 1987 |
| Grant date | Jul 10, 1990 |
| Priority date | — |
| Expiry date | Jun 8, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/862
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to monoclonal antibodies and hybridomas which produce them, which react with IgE when it is unbound and thereby inhibit IgE binding to mast cells, and react with IgE when it is bound to the B-cell FcE receptor, but do not react with IgE when it is bound to the mast cell FcE receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.